Metraipolis › archive › dc_2496a46fbd48

Rapidly Progressive Triple M Overlap Syndrome After Immune Checkpoint Inhibitor Therapy — Europe PMC PMID:42438578

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42438578
DOI
10.7759/cureus.112508
License (as archived)
solo-consultazione
Archived
2026-10-18T07:58:40.972Z
SHA-256 of the archived text
5f045809284e53167dbc016e24e2f1a7070bc24d19226c42ad3437070b5be6ed
Stable URL of this page
https://metraipolis.com/documento/dc_2496a46fbd48

How to cite

Rapidly Progressive Triple M Overlap Syndrome After Immune Checkpoint Inhibitor Therapy — Europe PMC PMID:42438578 — Europe PMC (en), https://europepmc.org/article/MED/42438578 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2496a46fbd48 (Metraipolis archive dc_2496a46fbd48, sha256 5f045809284e53167dbc016e24e2f1a7070bc24d19226c42ad3437070b5be6ed)
BibTeX
@misc{dc2496a46fbd48,
  title = {Rapidly Progressive Triple M Overlap Syndrome After Immune Checkpoint Inhibitor Therapy — Europe PMC PMID:42438578},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42438578},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2496a46fbd48; sha256 5f045809284e53167dbc016e24e2f1a7070bc24d19226c42ad3437070b5be6ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42438578. Agents can read the archived copy with the MCP tool read_document.